Alexander Kiani

6PUBLICATIONS
45CO-AUTHORS
Haematological tumoursEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 19, 2026
Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Delphine Rea, Slawomira Kyrcz-Krzemien, Paolo Sportoletti

|Nov 06, 2024
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia.

Leo Ruhnke, Marius Bill, Sven Zukunft

|Mar 29, 2024
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.

Annamaria Brioli, Elza Lomaia, Christian Fabisch

|May 31, 2022
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.

Laura E Fischer, Sebastian Stintzing, Ludwig Fischer von Weikersthal

|Jun 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.

Alexander Kiani, Romina Roesch, Clemens M Wendtner

Pageof 1

Frequent Collaborators

2 joint publications

Stefan W Krause

1 joint publications

Romina Roesch

1 joint publications

Lorenz Bastian

1 joint publications

Jan Kässens